PIH TB Leader Urges Faster Rollout of New Treatments

Posted on Apr 18, 2019

Broader use of new MDR-TB drugs in treatment settings would bring immediate benefits to patients, Dr. KJ Seung of PIH and Dr. Cathy Hewison of MSF write in The Lancet Global Health this week.

COVID Pandemic Devastating to Global TB Care, But Could Bring Positive Change

Posted on Mar 24, 2021

COVID-19 has severely disrupted care and services for people with tuberculosis, costing hundreds of thousands of lives—but safety protocols, infrastructure, and testing capacity implemented for the pandemic could have long-term benefits for TB patients around the world, a PIH physician says.

Please send donations to: Partners In Health, PO Box 996, Frederick, MD 21705-9942